ValitaCell selected for Startup Creasphere accelerator

Start Up creasphere

ValitaCell, has been selected as one of 11 high potential global start-ups to join the prestigious health tech accelerator programme Startup Creasphere

The Startup Creasphere innovation programme matches global pharmaceutical partners including Roche, Sanofi and Lonza with the Worlds most innovative and disruptive health tech start-ups.

The global healthcare giant Lonza has chosen to collaborate with Valitacell as their chosen high potential start up for the 3-month programme. 

Established in 2018, by Roche and Plug and Play, Startup Creasphere is a Munich based Digital Health Accelerator program.

Commenting on the partnership, Dr. Stephanie Davies, Head of Cell Therapy at ValitaCell said

ValitaCell is delighted to have been chosen by Lonza for this 3 month accelerator programme and we look forward to working with Lonza to transform healthcare together”.

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!

    I agree to receive marketing communication from ValitaCell by e-mail

    The controller of your personal data is ValitaCell. We process your personal data in order to respond to your questions and for sending marketing communication, if you agreed. You have the right to access data, the right to request rectification, deletion or limitation of their processing, data transfer, the right to object, as well as the right to lodge a complaint to the supervisory body. Full information about processing of personal data can be found in the Privacy Policy.

    Show More